CLINICAL APPROACH TO HEREDITARY HEMORRHAGIC TELANGIECTASIA

Journal Title: Journal of IMAB - Annual Proceeding (Scientific Papers) - Year 2013, Vol 19, Issue 3

Abstract

Background: Hereditary hemorrhagic telangiectasia (HHT or Rendu-Osler-Weber disease) is a rare syndrome, inherited as an autosomal dominant trait with incidence of 1/10000. The clinical manifestations are due to vascular malformations and predisposition to hemorrhages in different organs, the leading symptom being recurrent epistaxis. If diagnosed with HHT, the patient and his relatives and especially children have to be screened for occult vascular malformations. Case report: A 30 years old woman was treated for cerebral stroke, epistaxis, anemia, arterio-venous malformations for over 6 months. Only at this point she was diagnosed with HHT, after noticing the typical mucosal changes. Focused family history revealed symptoms of HHT in her only child, her father, aunt and two cousins The child was screened for occult vascular malformations – attainment of the nasal mucosa, lungs, gastrointestinal system, liver and brain. Pulmonary and gastrointestinal arterio-venous malformations were proven. Conclusion: Any case of recurrent epistaxis should be evaluated for HHT. After confirmation of the diagnosis every patient and close relatives have to be screened for attainment of other organs and followed up in order to prevent severe life threatening complications.

Authors and Affiliations

Mary Hachmeriyan, Nikolai Sapundzhiev, Miglena Georgieva, Nataliq Dobrudjanska, Venislav Stoyanov, Dimitrina Konstantinova, Lyudmila Angelov

Keywords

Related Articles

LEGAL ASPECTS OF DIRECT-TO-CONSUMER GENETIC TESTS.

Genetic testing is a type of medical test that identifies changes in chromosomes, genes, or proteins. Most of the time, testing is used to find changes that are associated with inherited disorders. The results of a genet...

COMPARATIVE CYTOTOXICITY EVALUATION OF MEDICINES USED FOR PULPTHERAPY OF PRIMARY TEETH

Introduction:Despite the eight decades of widespread clinical use of formocresol growing evidence from both experimental and clinical studies clearly indicates that formaldehyde is leaking out during pulpotomy and may pa...

 GENDER DISPARITY IN PREVALENCE OF TUBERCULOSIS IN REGION VARNA IN 2012.

 Aim: To assess the gender differences among suspected pulmonary tuberculosis patients undergoing diagnostic sputum smear microscopy. Materials and methods: The study covered the patients with TBC diagnosed and tr...

 CORRELATION OF GENE EXPRESSION OF MAIN INFLAMMATORY CITOKINS AND THE SEVERITY OF CHRONIC PERIODONTITIS.

 The understanding of the pathogenesis of periodontitis makes various progresses in the last decades. Today it is well known that the synthesis of high levels of pro-inflammatory mediators from gingival tissues in r...

 SINGLE AGENT DOCETAXEL AS SECOND- LINE CHEMOTHERAPY FOR PRETREATED PATIENTS WITH RECURRENT NON- SMALL CELL LUNG CANCER

 Objective: Single agent Docetaxel is a standard therapy for patients with non- small cell lung cancer after the failure of platinum- containing regimens. The aim of this study was to explore the efficacy and safety...

Download PDF file
  • EP ID EP99017
  • DOI 10.5272/jimab.2013193.453
  • Views 138
  • Downloads 0

How To Cite

Mary Hachmeriyan, Nikolai Sapundzhiev, Miglena Georgieva, Nataliq Dobrudjanska, Venislav Stoyanov, Dimitrina Konstantinova, Lyudmila Angelov (2013). CLINICAL APPROACH TO HEREDITARY HEMORRHAGIC TELANGIECTASIA. Journal of IMAB - Annual Proceeding (Scientific Papers), 19(3), 453-456. https://europub.co.uk/articles/-A-99017